Bixiye
BCBSMN-PharmProgPolicyNotif-Effective-100121.pdf
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1561 - 1570 ee natiijooyinka 3563
Bixiye
QP64-21 Patient360 Enhancement for Minnesota Health Care Programs Members
Taariikhda barnaamijka Dhaqangalayso Agosto 11, 2021
Bixiye
QP62-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective October 1, 2021
Taariikhda barnaamijka Dhaqangalayso Agosto 11, 2021
Bixiye
QP63-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Empaveli (pegcetacoplan)
Taariikhda barnaamijka Dhaqangalayso Agosto 11, 2021
Bixiye
QP65-21 Minnesota Health Care Programs Providers use of the Interactive Care Reviewer
Taariikhda barnaamijka Dhaqangalayso Agosto 11, 2021
Bixiye
P45-21 Behavioral Health Coding for Early Intensive Behavioral Intervention and Applied Behavioral Analysis
Taariikhda barnaamijka Dhaqangalayso Agosto 02, 2021
Bixiye
P44-21 Urine Drug Testing Reimbursement Policy
Taariikhda barnaamijka Dhaqangalayso Agosto 02, 2021
Bixiye
P48-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda barnaamijka Dhaqangalayso Agosto 02, 2021
Bixiye
P47-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective October 4, 2021
Taariikhda barnaamijka Dhaqangalayso Agosto 02, 2021